Counter-selection for over-expressed human CD44s in primary tumors versus lung metastases in a mouse fibrosarcoma model

被引:18
作者
Kogerman, P
Sy, MS
Culp, LA
机构
[1] CASE WESTERN RESERVE UNIV,SCH MED,DEPT MOL BIOL & MICROBIOL,CLEVELAND,OH 44106
[2] CASE WESTERN RESERVE UNIV,SCH MED,DEPT PATHOL,CLEVELAND,OH 44106
关键词
CD44; metastasis; nude mice; 3T3; sis;
D O I
10.1038/sj.onc.1201306
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human CD44 standard isoform cDNA (hCD44s) was transfected into sis-transformed Balb/c 3T3 cells and into ras-revertant IIIA4 cells (both tumorigenic but nonmetastatic). Transfectants were injected subcutaneously into athymic nude mice to elucidate the functional role of hCD44s over-expression in progression and metastasis. The transfectants (but not parental cells) vr ere capable of lung micrometastasis and of binding exogenously-added hyaluronan. hCD44s protein expression was conserved in lung micrometastases suggesting that it may have been necessary for their formation. In contrast, no hCD44s protein was detected in large subcutaneous (s.c.) tumors but normal levels of murine CD44 were detected. A second round of tumor development, using these two tumor cell classes, demonstrated that hCD44s-nonexpressing s.c. tumor cells re-expressed it in lung micrometastases. Conversely, hCD44s-expressing lung micrometastatic cells, when injected into a second group of mice, downregulated hCD44s expression in order to grow sizable s.c. tumors. S.c. tumor cells still contained the hCD44s gene but its expression was inhibited by epigenetic mechanisms, one of which was shown to be methylation of the hCD44s gene. These studies demonstrate (a) opposing selective pressures on CD44s over-expression for s.c. tumor growth and for metastatic spread to the lung and (b) further credence for the significance of CD44 for metastatic spread of fibrosarcomas. Therefore, CD44s may he a critical component of the metastatic phenotype induced by specific oncogenes.
引用
收藏
页码:1407 / 1416
页数:10
相关论文
共 32 条
  • [1] BINDING AND DEGRADATION OF HYALURONAN BY HUMAN BREAST-CANCER CELL-LINES EXPRESSING DIFFERENT FORMS OF CD44 - CORRELATION WITH INVASIVE POTENTIAL
    CULTY, M
    SHIZARI, M
    THOMPSON, EW
    UNDERHILL, CB
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 1994, 160 (02) : 275 - 286
  • [2] THE HYALURONAN RECEPTOR (CD44) PARTICIPATES IN THE UPTAKE AND DEGRADATION OF HYALURONAN
    CULTY, M
    NGUYEN, HA
    UNDERHILL, CB
    [J]. JOURNAL OF CELL BIOLOGY, 1992, 116 (04) : 1055 - 1062
  • [3] CD44 and its ligand hyaluronate mediate rolling under physiologic flow: A novel lymphocyte-endothelial cell primary adhesion pathway
    DeGrendele, HC
    Estess, P
    Picker, LJ
    Siegelman, MH
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (03) : 1119 - 1130
  • [4] MODULATION OF TUMOR-CELL RESPONSE TO CHEMOTHERAPY BY THE ORGAN ENVIRONMENT
    FIDLER, IJ
    WILMANNS, C
    STAROSELSKY, A
    RADINSKY, R
    DONG, ZY
    FAN, D
    [J]. CANCER AND METASTASIS REVIEWS, 1994, 13 (02) : 209 - 222
  • [5] FOX SB, 1994, CANCER RES, V54, P4539
  • [6] GOROWSKI JJ, 1995, J BIOL CHEM, V270, P26940
  • [7] A NEW VARIANT OF GLYCOPROTEIN CD44 CONFERS METASTATIC POTENTIAL TO RAT CARCINOMA-CELLS
    GUNTHERT, U
    HOFMANN, M
    RUDY, W
    REBER, S
    ZOLLER, M
    HAUSSMANN, I
    MATZKU, S
    WENZEL, A
    PONTA, H
    HERRLICH, P
    [J]. CELL, 1991, 65 (01) : 13 - 24
  • [8] GUO YJ, 1994, CANCER RES, V54, P1561
  • [9] MONOCLONAL ANTI-CD44 ANTIBODY ACTS IN SYNERGY WITH ANTI-CD2 BUT INHIBITS ANTI-CD3 OR T-CELL RECEPTOR-MEDIATED SIGNALING IN MURINE T-CELL HYBRIDOMAS
    GUO, YJ
    MA, J
    WONG, JH
    LIN, SC
    CHANG, HC
    BIGBY, M
    SY, MS
    [J]. CELLULAR IMMUNOLOGY, 1993, 152 (01) : 186 - 199
  • [10] HEIDER KH, 1993, CANCER RES, V53, P4197